.Nature Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint asks for addition of people with MASLD and size of liver results in cardio-- renal-- metabolic trials, when information propose mechanistically tenable perks as well as clinical protection-- and lays out points to consider for test design as well as regulative commendation.